Maria Flavia Di Renzo

Cancer Genetics (United States) — United States

Medicine · Health Sciences

45h-index8.9kcitations206works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(75), Hepatocellular Carcinoma Treatment and Prognosis(23), Cholangiocarcinoma and Gallbladder Cancer Studies(22), Virus-based gene therapy research(18), Cancer Cells and Metastasis(16)

Publications206 total

Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Materials and Methods from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Figure S1 from The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel <i>In vivo</i>
2023Open Access
Data from The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel <i>In vivo</i>
2023Open Access
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Data from The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel <i>In vivo</i>
2023Open Access
Supplementary Figure S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Figure S1 from The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel <i>In vivo</i>
2023Open Access
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Paolo M. Comoglio(34), Martina Olivero(31), Silvia Giordano(11), Riccardo Ferracini(7), Katia Scotlandi(6), Piera Maggiora(5), Guido Valente(5), María Prat(5), Antonella De Stefani(4), G Cortesina(4), Antonino Belfiore(4), Angela Costantino(4), Chiara Bardella(4), Maria Cristina Manara(4), Jessica Erriquez(4), Luigi Naldini(3), Tiziana Martone(3), Riccardo Vigneri(3), Nicola Baldini(3), Pier‐Luigi Lollini(3)